![]() ![]() This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. But looking back on that evening in February 2022, it shouldn’t have been a surprise. He couldn’t imagine that he would use the medicine less than two hours later. Walking along a rail platform, a veteran transit worker spotted a package of the opioid overdose-reversing drug naloxone, picked it up and slipped it in his vest. (Wernau, 6/11)Ī Metro Worker Revived 21 Riders Overdosing On Opioids “This is the aftermarket me,” he said. This is what recovery looks like for drug users disfigured by xylazine, or “tranq,” an animal tranquilizer mixed into America’s increasingly toxic illicit drug supply. He flashed a cheeky grin and took a selfie with his new titanium fingers wrapped around the cup. Tranq Made It Worseĭavid “Lee” Wells marveled at how it felt to hold an iced coffee in his hand again after losing his fingers to “tranq” wounds that rotted away his flesh. Critics argue it enables illegal activity. Advocates say it acknowledges the importance of keeping people alive, first and foremost, while they confront the sometimes insurmountable challenges associated with recovery. The so-called harm reduction model, which has received endorsement and funding from the Biden administration, offers potentially life-saving services to opioid users, without requiring abstinence in return. (Silverman, 6/9)Ībstinence Not Required: How A Baltimore Drug Treatment Program Prioritizes Saving Lives for more than a decade and contributed to thousands of overdose deaths. The editors announce a new series of Perspective articles focusing on the multifaceted relationship between U.S. Two large drugmakers and two of the biggest pharmacy chains finalized a $17.3 billion deal to settle accusations by state governments that they contributed to the opioid crisis that swept across the U.S. Debra Malina, Ph.D., Genevra Pittman, M.P.H., and Stephen Morrissey, Ph.D. (Facher, 6/10)ĭrug Companies, Pharmacies Reach $17B Opioid Settlement should work to develop new products and technologies that facilitate drug-checking. must ensure that test strips are legal and widely available, the officials wrote in a New England Journal of Medicine perspective published Saturday. Amid a devastating overdose epidemic, the U.S. The government’s top addiction scientists and key public health officials are calling for more research into fentanyl test strips. Top Health Officials Call For More Research On Fentanyl Test Strips Separately, a $17 billion opioid settlement was reached. The government's top addiction scientists and key public health officials are asking for more research into how fentanyl test strips could be better used, for clinical purposes as well as overdose prevention. Health Officials Push For Maximizing Potential Of Fentanyl Test Strips ![]()
0 Comments
Leave a Reply. |
AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |